HPV and lung cancer risk: A meta-analysis

Journal of Clinical Virology

Volumn 63, Issue , 2015, Pages 84-90

  Zhai, Kan ^a   Ding, Jie ^a   Shi, Huan Zhong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

HPV; Lung cancer; Meta analysis; Risk

Indexed keywords

CANCER RISK; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; META ANALYSIS; PAPILLOMAVIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL LUNG CARCINOMA; WART VIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; RISK ASSESSMENT; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LUNG NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT;

EID: 84921289423     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.09.014     Document Type: Review

References (49)

1. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers - a different disease. Nat Rev Cancer 2007, 7:778-790.
2. Spyratos D., Zarogoulidis P., Porpodis K., Tsakiridis K., Machairiotis N., Katsikogiannis N., et al. Occupational exposure and lung cancer. J Thorac Dis 2013, 5:S440-S445.
3. Syrjänen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res 2012, 32:3235-3250.
4. Brennan P., Hainaut P., Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011, 12:399-408.
5. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007, 23:297-313.
6. Munger K., Werness B.A., Dyson N., Phelps W.C., Harlow E., Howley P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989, 8:4099-4105.
7. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248:76-79.
8. Stanley M.A., Pett M.R., Coleman N. HPV: from infection to cancer. Biochem Soc Trans 2007, 35:1456-1460.
9. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
10. Steenbergen R.D., de Wilde J., Wilting S.M., Brink A.A., Snijders P.J., Meijer C.J. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005, 32(Suppl. 1):S25-S33.
11. Heideman D.A., Waterboer T., Pawlita M., Delis-van Diemen P., Nindl I., Leijte J.A., et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 2007, 25:4550-4556.
12. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475.
13. Hobbs C.G., Sterne J.A., Bailey M., Heyderman R.S., Birchall M.A., Thomas S.J. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006, 31:259-266.
14. Syrjänen S., Lodi G., von Bultzingslowen I., Aliko A., Arduino P., Campisi G., et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011, 17(Suppl. 1):58-72.
15. Syrjänen K.J. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 1979, 38:299-304.
16. Syrjänen K.J. HPV infections and lung cancer. J Clin Pathol 2002, 55:885-891.
17. Srinivasan M., Taioli E., Ragin C.C. Human papillomavirus type 16 and 18 in primary lung cancers - a meta-analysis. Carcinogenesis 2009, 30:1722-1728.
18. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
19. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
20. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Yu Y., Yang A., Hu S., Yan H. Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 2009, 21:1627-1632.
23. Yu Y., Yang A., Hu S., Zhang J., Yan H. Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas. Clin Respir J 2013, 7:27-33.
24. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001, 61:2799-2803.
25. Cheng Y.W., Chiou H.L., Chen J.T., Chou M.C., Lin T.S., Lai W.W., et al. Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer 2004, 46:165-170.
26. Li Q., Hu K., Pan X., Cao Z., Yang J., Hu S. Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J (Engl) 1995, 108:610-614.
27. Fei Y., Yang J., Hsieh W.C., Wu J.Y., Wu T.C., Goan Y.G., et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 2006, 36:274-279.
28. Nadji S.A., Mokhtari-Azad T., Mahmoodi M., Yahyapour Y., Naghshvar F., Torabizadeh J., et al. Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 2007, 248:41-46.
29. Wang Y., Wang A., Jiang R., Pan H., Huang B., Lu Y., et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep 2008, 20:333-339.
30. Wang Y.H., Chen D.J., Yi T.N., Liu X.H. The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue. Saudi Med J 2010, 31:1331-1336.
31. Carpagnano G.E., Koutelou A., Natalicchio M.I., Martinelli D., Ruggieri C., Di Taranto A., et al. HPV in exhaled breath condensate of lung cancer patients. Br J Cancer 2011, 105:1183-1190.
32. Sarchianaki E., Derdas S.P., Ntaoukakis M., Vakonaki E., Lagoudaki E.D., Lasithiotaki I., et al. Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol 2013, 10.1007/s13277-013-1419-2.
33. Pao C.C., Lin S.S., Lin C.Y., Maa J.S., Lai C.H., Hsieh T.T. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 1991, 95:540-546.
34. Liu V.W., Tsang P., Yip A., Ng T.Y., Wong L.C., Ngan H.Y. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol 2001, 82:269-272.
35. Dong S.M., Pai S.I., Rha S.H., Hildesheim A., Kurman R.J., Schwartz P.E., et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev 2002, 11:3-6.
36. Chiou H.L., Wu M.F., Liaw Y.C., Cheng Y.W., Wong R.H., Chen C.Y., et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003, 97:1558-1563.
37. Jain N., Singh V., Hedau S., Kumar S., Daga M.K., Dewan R., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005, 128:3999-4007.
38. Simen-Kapeu A., Surcel H.M., Koskela P., Pukkala E., Lehtinen M. Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:1879-1881.
39. Ragin C., Obikoya-Malomo M., Kim S., Chen Z., Flores-Obando R., Gibbs D., et al. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis 2014, 10.1093/carcin/bgu038.
40. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
41. Krikelis D., Tzimagiorgis G., Georgiou E., Destouni C., Agorastos T., Haitoglou C., et al. Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: memories of viral infection. J Clin Virol 2010, 49:169-174.
42. Sagerup C.M., Nymoen D.A., Halvorsen A.R., Lund-Iversen M., Helland A., Brustugun O.T. Human papilloma virus detection and typing in 334 lung cancer patients. Acta Oncol 2014, 10.3109/0284186X.2013.879608.
43. Wang J.L., Fang C.L., Wang M., Yu M.C., Bai K.J., Lu P.C., et al. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma. Int J Cancer 2014, 134:65-71.
44. Wu Y., Chen Y., Li L., Yu G., Zhang Y., He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006, 35:264-269.
45. Gravitt P.E., Kovacic M.B., Herrero R., Schiffman M., Bratti C., Hildesheim A., et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 2007, 121:2787-2793.
46. Huang Y., Huang M.N., Li N., Li X.G., Wu L.Y. Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int J Gynecol Cancer 2008, 18:755-760.
47. Kimple A.J., Torres A.D., Yang R.Z., Kimple R.J. HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification. Sensors 2012, 12:5159-5169.
48. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
49. Lee P.N., Forey B.A., Coombs K.J. Systematic review with meta-analysis of the epidemiological evidence in the 1900 relating smoking to lung cancer. BMC Cancer 2012, 12:385.